Inventurus Knowledge Solutions (IKS) Stock Overview
Operates as a technology-enabled healthcare solutions provider. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for IKS from our risk checks.
IKS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Inventurus Knowledge Solutions Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,728.90 |
| 52 Week High | ₹1,933.00 |
| 52 Week Low | ₹1,262.00 |
| Beta | 0 |
| 1 Month Change | -7.13% |
| 3 Month Change | 3.21% |
| 1 Year Change | 12.16% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.83% |
Recent News & Updates
AI-Powered Healthcare Platform Expansion Will Reshape Long-Term Earnings Potential
Catalysts About Inventurus Knowledge Solutions Inventurus Knowledge Solutions, through IKS Health, provides technology enabled healthcare operations and revenue cycle services for provider organizations. What are the underlying business or industry changes driving this perspective?Industry Analysts Just Upgraded Their Inventurus Knowledge Solutions Limited (NSE:IKS) Revenue Forecasts By 23%
Inventurus Knowledge Solutions Limited ( NSE:IKS ) shareholders will have a reason to smile today, with the analysts...Inventurus Knowledge Solutions Limited Just Missed EPS By 7.2%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Inventurus Knowledge Solutions Limited ( NSE:IKS ), which a week ago released...Recent updates
AI-Powered Healthcare Platform Expansion Will Reshape Long-Term Earnings Potential
Catalysts About Inventurus Knowledge Solutions Inventurus Knowledge Solutions, through IKS Health, provides technology enabled healthcare operations and revenue cycle services for provider organizations. What are the underlying business or industry changes driving this perspective?Industry Analysts Just Upgraded Their Inventurus Knowledge Solutions Limited (NSE:IKS) Revenue Forecasts By 23%
Inventurus Knowledge Solutions Limited ( NSE:IKS ) shareholders will have a reason to smile today, with the analysts...Inventurus Knowledge Solutions Limited Just Missed EPS By 7.2%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Inventurus Knowledge Solutions Limited ( NSE:IKS ), which a week ago released...Inventurus Knowledge Solutions Limited (NSE:IKS) Annual Results: Here's What Analysts Are Forecasting For This Year
Shareholders might have noticed that Inventurus Knowledge Solutions Limited ( NSE:IKS ) filed its yearly result this...Inventurus Knowledge Solutions Limited (NSE:IKS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
It's been a good week for Inventurus Knowledge Solutions Limited ( NSE:IKS ) shareholders, because the company has just...Inventurus Knowledge Solutions (NSE:IKS) Could Be Struggling To Allocate Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...Inventurus Knowledge Solutions (NSE:IKS) Could Easily Take On More Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Here's Why Inventurus Knowledge Solutions (NSE:IKS) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Why Investors Shouldn't Be Surprised By Inventurus Knowledge Solutions Limited's (NSE:IKS) P/E
Inventurus Knowledge Solutions Limited's ( NSE:IKS ) price-to-earnings (or "P/E") ratio of 55.3x might make it look...Shareholder Returns
| IKS | IN Healthcare Services | IN Market | |
|---|---|---|---|
| 7D | -3.1% | 0.3% | -2.3% |
| 1Y | 12.2% | -26.3% | -4.1% |
Return vs Industry: IKS exceeded the Indian Healthcare Services industry which returned -26.3% over the past year.
Return vs Market: IKS exceeded the Indian Market which returned -4.1% over the past year.
Price Volatility
| IKS volatility | |
|---|---|
| IKS Average Weekly Movement | 4.5% |
| Healthcare Services Industry Average Movement | 7.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 8.9% |
| 10% least volatile stocks in IN Market | 3.4% |
Stable Share Price: IKS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: IKS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 9,698 | Sachin Gupta | ikshealth.com |
Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform and associated services predominantly to healthcare enterprises in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations.
Inventurus Knowledge Solutions Limited Fundamentals Summary
| IKS fundamental statistics | |
|---|---|
| Market cap | ₹296.63b |
| Earnings (TTM) | ₹7.64b |
| Revenue (TTM) | ₹33.47b |
Is IKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IKS income statement (TTM) | |
|---|---|
| Revenue | ₹33.47b |
| Cost of Revenue | ₹16.88b |
| Gross Profit | ₹16.60b |
| Other Expenses | ₹8.96b |
| Earnings | ₹7.64b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 44.51 |
| Gross Margin | 49.58% |
| Net Profit Margin | 22.82% |
| Debt/Equity Ratio | 26.9% |
How did IKS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/17 16:55 |
| End of Day Share Price | 2026/09/17 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Inventurus Knowledge Solutions Limited is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Soumitra Chatterjee | Avendus Spark |
| Vijayaraghavan Swaminathan | Avendus Spark |
| Ravi Menon | Axis Capital Limited |